Daily Archives: January 14, 2019

First trimester ondansetron exposure was not associated with an increased risk of overall congenital malformations or cardiac malformations after adjustment for known confounders.

First trimester ondansetron exposure was not associated with an increased risk of overall congenital malformations or cardiac malformations after adjustment for known confounders.

HIV in pregnancy

The United States Department of Health and Human Services (DHHS) recently updated its guidelines on the use of antiretroviral agents in pregnant women with HIV infection. Dolutegravir is newly listed as a preferred agent to initiate during the second and third trimester of pregnancy. However, the guidelines reiterate a conservative interim recommendation that dolutegravir not…